Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease
- PMID: 28295971
- DOI: 10.1002/ccd.26984
Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease
Abstract
Purpose: To assess the intraprocedural and mid-term outcomes of orbital atherectomy (OA) combined with drug-coated balloon (DCB) angioplasty for the treatment of calcified femoropopliteal disease.
Methods: In this single-center cohort, 89 patients (139 lesions) were treated with DCB angioplasty for claudication or critical limb ischemia (CLI). Angiographic characteristics and procedural outcomes were reviewed for patients treated with or without adjunctive OA. Lesion calcification was graded using two previously published scoring systems, the angiographic calcium score (ACS) and the peripheral artery calcification scoring system (PACSS).
Results: Among 139 lesions, 40 (29%) were treated with OA + DCB. Mean lesion length was 135 ± 100 mm for lesions treated with OA + DCB and 139 ± 100 mm for DCB alone (P = 0.9). Moderate to severe calcification was present in 83% of patients treated with OA, compared to 42% of patients treated with DCB alone (P < 0.001). Lesions treated with OA + DCB were less likely to require bailout stenting (18% vs. 39%, P =0.01). Rates of embolization (0% in OA + DCB vs. 2% in DCB only, P = 0.4), dissection (13% vs. 14%, P = 0.8), and perforation (0%) did not differ significantly between groups. The freedom from TLR at 1 year was 82% in both groups (P = 0.6) while primary patency was 81% in-patients treated with DCB alone and 77% in-patients treated with DCB with concomitant OA (P = 0.8).
Conclusion: In this single-center analysis of patients undergoing DCB angioplasty for claudication or CLI, OA was most often used for the treatment of severely calcified lesions. These lesions were more likely to be treated with scoring balloons and less likely to require bailout stenting. At 1 year, target lesion revascularization and primary patency was similar in patients treated with and without adjunctive OA, despite the higher lesion complexity among those receiving the combination procedure. © 2017 Wiley Periodicals, Inc.
Keywords: calcification; peripheral artery disease; peripheral intervention; superficial femoral artery.
© 2017 Wiley Periodicals, Inc.
Comment in
-
Between a Rock and a Hard Place: Adventures in Treating Calcific Femoropopliteal Disease.Catheter Cardiovasc Interv. 2017 May;89(6):1085-1086. doi: 10.1002/ccd.27069. Catheter Cardiovasc Interv. 2017. PMID: 28488406
Similar articles
-
Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions.J Endovasc Ther. 2020 Jun;27(3):492-501. doi: 10.1177/1526602820915244. Epub 2020 May 4. J Endovasc Ther. 2020. PMID: 32364000
-
Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes.Ann Vasc Surg. 2021 May;73:222-233. doi: 10.1016/j.avsg.2020.10.051. Epub 2021 Jan 21. Ann Vasc Surg. 2021. PMID: 33359329
-
Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.Cardiovasc Revasc Med. 2019 Mar;20(3):210-214. doi: 10.1016/j.carrev.2018.06.018. Epub 2018 Jun 25. Cardiovasc Revasc Med. 2019. PMID: 29970328
-
Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.J Endovasc Ther. 2020 Aug;27(4):647-657. doi: 10.1177/1526602820931559. Epub 2020 Jun 7. J Endovasc Ther. 2020. PMID: 32508220
-
Vessel Preparation in Infrapopliteal Arterial Disease: A Systematic Review and Meta-Analysis.J Endovasc Ther. 2024 Apr;31(2):191-202. doi: 10.1177/15266028221120752. Epub 2022 Sep 4. J Endovasc Ther. 2024. PMID: 36062761 Free PMC article.
Cited by
-
Comparison of Balloon Angioplasty and Stent Implantation for Femoropopliteal Disease According to Patient and Lesion Subgroup.Circ Rep. 2019 Feb 1;1(2):94-101. doi: 10.1253/circrep.CR-18-0028. Circ Rep. 2019. PMID: 33693119 Free PMC article.
-
The efficacy and safety of atherectomy combined with drug-coated balloon angioplasty vs. drug-coated balloon angioplasty for the treatment of lower extremity artery disease: a systematic review and meta-analysis.Front Cardiovasc Med. 2024 Sep 27;11:1472064. doi: 10.3389/fcvm.2024.1472064. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39399517 Free PMC article.
-
Intravascular Lithotripsy for Peripheral Artery Calcification: Mid-term Outcomes From the Randomized Disrupt PAD III Trial.J Soc Cardiovasc Angiogr Interv. 2022 May 19;1(4):100341. doi: 10.1016/j.jscai.2022.100341. eCollection 2022 Jul-Aug. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39131928 Free PMC article.
-
Atherectomy Plus Balloon Angioplasty for Femoropopliteal Disease Compared to Balloon Angioplasty Alone: A Systematic Review and Meta-analysis.J Soc Cardiovasc Angiogr Interv. 2022 Aug 30;1(6):100436. doi: 10.1016/j.jscai.2022.100436. eCollection 2022 Nov-Dec. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39132346 Free PMC article. Review.
-
Use of rotational atherectomy for reducing significant dissection in treating de novo femoropopliteal steno-occlusive disease after balloon angioplasty.J Geriatr Cardiol. 2018 Apr;15(4):254-260. doi: 10.11909/j.issn.1671-5411.2018.04.006. J Geriatr Cardiol. 2018. PMID: 29915614 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous